ASLAN Pharmaceuticals Limited

ASLN · NASDAQ
Analyze with AI
3/31/2024
12/31/2023
9/30/2023
6/30/2023
Assets
Cash & Equivalents$18,396$21,252$40,818$40,944
Short-Term Investments$0$0$0$0
Receivables$0$171$0$12,000
Inventory$0$0$0$0
Other Curr. Assets$2,179$2,706$3,474$2,135
Total Curr. Assets$20,576$24,130$44,292$55,079
Property Plant & Equip (Net)$176$259$340$123
Goodwill$0$0$0$0
Intangibles$0$2$0$4
Long-Term Investments$236$236$0$0
Tax Assets$0-$2$0$0
Other NC Assets$0$2$0$0
Total NC Assets$413$497$343$127
Other Assets$0$0$0$0
Total Assets$20,988$24,627$44,635$55,206
Liabilities
Payables$9,656$7,919$4,423$6,305
Short-Term Debt$7,316$2,027$13,788$13,451
Tax Payable$0$0$0$0
Deferred Revenue$2,351$0$2,328$2,414
Other Curr. Liab.$281$3,170$439$2,189
Total Curr. Liab.$19,604$13,115$20,978$24,358
LT Debt$19,350$24,799$24,539$24,477
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$19,350$24,799$24,539$24,477
Other Liabilities$0$0$0$0
Cap. Leases$150$226$300$68
Total Liabilities$38,953$37,913$45,517$48,835
Equity
Pref Stock$0$0$0$0
Common Stock$65,189$63,932$63,850$63,701
Retained Earnings-$330,987-$321,067-$309,094-$299,385
AOCI$57$24,074-$179-$179
Other Equity$247,776$219,774$244,541$242,234
Total Equity-$17,965-$13,287-$882$6,371
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$20,988$24,627$44,635$55,206
Net Debt$8,269$5,573-$2,491-$3,017
ASLAN Pharmaceuticals Limited (ASLN) Financial Statements & Key Stats | AlphaPilot